Biorestorative Therapies Inc (BRTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Sales | 401 | 146 | 120 | 46 | 77 |
| Cost of Goods | 28 | N/A | N/A | N/A | N/A |
| Gross Profit | 373 | 146 | 120 | 46 | 77 |
| Operating Expenses | 11,956 | 15,367 | 19,094 | 26,354 | 2,829 |
| Operating Income | -11,555 | -15,221 | -18,974 | -26,308 | -2,752 |
| Interest Expense | -616 | -552 | -12 | 1,815 | 1,640 |
| Other Income | 1,960 | 4,251 | 468 | -16,180 | -6,881 |
| Pre-tax Income | -8,979 | -10,418 | -18,495 | -44,303 | -11,273 |
| Net Income Continuous | -8,979 | -10,418 | -18,495 | -44,303 | -11,273 |
| Net Income | $-8,979 | $-10,418 | $-18,495 | $-44,303 | $-11,273 |
| EPS Basic Total Ops | -1.16 | -2.47 | -5.11 | -37.30 | -28.56 |
| EPS Basic Continuous Ops | -1.16 | -2.47 | -5.11 | -37.30 | -28.56 |
| EPS Diluted Total Ops | -1.16 | -2.47 | -5.11 | -37.30 | -28.56 |
| EPS Diluted Continuous Ops | -1.16 | -2.47 | -5.11 | -37.30 | -28.56 |
| EPS Diluted Before Non-Recurring Items | -1.36 | -3.42 | -5.11 | -37.30 | N/A |
| EBITDA(a) | $-11,366 | $-15,055 | $-18,854 | $-25,085 | $-1,353 |